Send to

Choose Destination
Breast Cancer Res Treat. 2018 Jul;170(1):55-67. doi: 10.1007/s10549-018-4738-6. Epub 2018 Mar 6.

Exercise and weight loss interventions and miRNA expression in women with breast cancer.

Author information

The RNA Institute, University at Albany State University of New York, Albany, NY, 12222, USA.
Investigative Medicine Program, Yale University Medical School, New Haven, CT, 06520, USA.
Department of RNA Sciences, The Brain Institute of America, Groton, CT, 06340, USA.
Department of Epidemiology and Biostatistics, Milken Institute of Public Health George Washington University, Washington, DC, 20052, USA.
Department of Exercise and Nutrition Sciences, Milken Institute of Public Health George Washington University, Washington, DC, 20052, USA.
Yale School of Public Health, New Haven, CT, 06510, USA.
Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, 06510, USA.
Yale Medical Oncology, Smilow Cancer Center at Yale New Haven Hospital, New Haven, CT, 06511, USA.
Division of Nucleic Acid Technology, Alexion Pharmaceuticals, Cheshire, CT, 06410, USA.
Yale School of Public Health, New Haven, CT, 06510, USA.



Obesity and weight gain are associated with comorbidities including a higher risk of tumor recurrence and cancer-related deaths among breast cancer (BC) survivors; however, the underlying mechanisms linking obesity and cancer are poorly understood. Given the lack of clinically validated BC biomarkers, obesity and weight-loss studies utilize serum biomarkers as the intermediary outcomes of tumor recurrence. Studies have indicated microRNAs (miRNA)s are reliable biomarkers for cancer. We hypothesized that miRNA expression correlates with obesity and weight loss amongst BC survivors. This would yield insight into the biological pathways by which this association occurs, enabling more precise development of therapeutics.


We correlated baseline body mass index (BMI) with serum miRNA expression in 121 BC survivors enrolled in the Hormones and Physical Exercise (HOPE) trial. We then analyzed expression of the 35 most abundant miRNAs from HOPE in a six-month randomized controlled weight-loss trial (Lifestyle, Exercise, and Nutrition; LEAN) in 100 BC survivors. Ingenuity pathway analysis (IPA) software was used to identify biological pathway targets of the BMI-associated and intervention-responsive miRNAs using predictive biomarkers.


Pearson correlations in HOPE identified eight miRNAs associated with BMI, including miR-191-5p (r = - 0.22, p = 0.016) and miR-122-5p (r = 0.25, p = 0.0048). In the LEAN validation study, levels of miR-191-5p significantly increased during the six-month intervention (p = 0.082). Ingenuity Pathway Analysis identified "Estrogen-mediated S-phase entry" (HOPE p = 0.003; LEAN p < 0.001) and "Molecular mechanisms of cancer" (HOPE p = 0.02; LEAN p < 0.001) as the top canonical pathways that significantly correlated with BMI-associated and intervention-responsive miRNAs and contain obesity and cancer-relevant genes including the E2F family of transcription factors and CCND1, which have been implicated in sporadic BC.


While the association between obesity and BC recurrence and mortality has been demonstrated in the literature, mechanisms underlying the link between weight gain and cancer are unclear. Using two independent clinical trials, we identified novel miRNAs associative to BMI and weight loss that contribute to the development of cancer. Predictive modeling of miRNA targets identified multiple canonical pathways associated with cancer, highlighting potential mechanisms explaining the link between BMI and increased cancer risk.


Biomarkers; Breast cancer; Diet; Exercise; MicroRNA; Obesity; Weight loss; miRNA

[Available on 2019-07-01]
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center